Somatostatin-producing endocrine tumour of the duodenum associated with type 1 neurofibromatosis

Acta Dermato-Venereologica

Volumn 90, Issue 3, 2010, Pages 320-321

  Pernet, Charlotte ^a   Kluger, Nicolas ^a   Du Thanh, Aurélie ^a   Guillon, Françoise ^a   Dereure, Olivier ^a   Bessis, Didier ^a   Guillot, Bernard ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; SOMATOSTATIN;

ADULT; CASE REPORT; DUODENUM TUMOR; ENDOCRINE TUMOR; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ESOPHAGOGASTRODUODENOSCOPY; HUMAN; LETTER; MALE; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SOMATOSTATINOMA; WORLD HEALTH ORGANIZATION;

CELL DIFFERENTIATION; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DUODENAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; SOMATOSTATINOMA; TREATMENT OUTCOME;

EID: 77953449283     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0844     Document Type: Letter

References (15)

1. Le LQ, Parada LF. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene 2007; 26: 4609-4616.
2. Fuller CE, Williams GT. Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology 1991; 19: 1-11.
3. Burke AP, Sobin LH, Federspiel BH, Shekitka KM, Helwig EB. Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Arch Pathol Lab Med 1990; 114: 700-704.
4. Garbrecht N, Anlauf M, Schmitt A, Henopp T, Sipos B, Raffel A, et al. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Endocr Relat Cancer 2008; 15: 229-241.
5. Soga J, Yakuwa Y. Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 1999; 18: 13-22. (Pubitemid 29232065)
6. Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004; 1014: 13-27.
7. Cappelli C, Agosti B, Braga M, Cumetti D, Gandossi E, Rizzoni D, et al. Von Recklinghausen's neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature. Minerva Endocrinol 2004; 29: 19-24.
8. Hamy A, Heymann MF, Bodic J, Visset J, Le Borgne J, Lenéel JC, et al. Duodenal somatostatinoma. Anatomic/clinical study of 12 operated cases. Ann Chir 2001; 126: 221-226.
9. Simon P, Spilcke-Liss E, Wallaschofski H. Endocrine tumors of the pancreas. Endocrinol Metab Clin North Am 2006; 35: 431-47, xii.
10. Sakorafas GH, Giannopoulos GA, Parasi A, Konstantoudakis G, Tzanakis N, Stergiopoulos S, et al. Large somatostatin-producing endocrine carcinoma of the ampulla of vater in association with GIST in a patient with von Recklinghausen's disease. Case report and review of the literature. JOP 2008; 9: 633-639.
11. Nesi G, Marcucci T, Rubio CA, Brandi ML, Tonelli F. Somatostatinoma: clinico-pathological features of three cases and literature reviewed. J Gastroenterol Hepatol 2008; 23: 521-526.
12. Krausz Y, Bar-Ziv J, de Jong RB, Ish-Shalom S, Chisin R, Shibley N, et al. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors. Am J Gastroenterol 1998; 93: 66-70.
13. Masson B, Desfourneaux V, Raymond JM, Beyssac R, Belleannee G. Somatostatinoma. Apropos of a case. J Chir (Paris) 1997; 134: 22-26.
14. Wheeler MH, Curley IR, Williams ED. The association of neurofibromatosis, pheochromocytoma, and somatostatin-rich duodenal carcinoid tumor. Surgery 1986; 100: 1163-1169.
15. Pinson S, Créange A, Barbarot S, Stalder JF, Chaix Y, Rodriguez D, et al. Neurofibromatosis 1: recommendations for management. Ann Dermatol Venereol 2001; 128: 567-575.